Comments
Loading...
Inozyme Pharma Insider Trading Activity | NASDAQ:INZY | Benzinga
Track the latest Inozyme Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for Inozyme Pharma stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Inozyme Pharma Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Inozyme Pharma Inc
Shares Outstanding
64.562M
Insider Shares Owned
739.938K
Insider Percentage Owned
1.15%
Institutional Shares Held
13.571M
Institutional Percentage Held
21.0%
| Apr 03, 2025 | Douglas A Treco | CEO & CHAIRMAN | 16.18K | $0.89 | -$7.85K | SELL-OPTIONS | 65.08% | 41.05K | Apr 01 - Apr 02 | View |
| Apr 03, 2024 | Douglas A Treco | CEO | 17.48K | $6.94 | -$52.21K | SELL-OPTIONS | 548.21% | 20.66K | Apr 01 - Apr 02 | View |
| Aug 03, 2023 | Pivotal bioVenture Partners Fund I LPPivotal bioVenture Partners Fund I GP LPPivotal bioVenture Partners Fund I UGP Ltd | — | 833.33K | $4.80 | $4.00M | BUY | 112.86% | 1.57M | Aug 01 | View |
| Aug 03, 2023 | Robert Hopfner | — | 833.33K | $4.80 | $4.00M | BUY | 112.86% | 1.57M | Aug 01 | View |
| May 15, 2023 | Robert Hopfner | DIRECTOR | 447.93K | $6.36 | $2.85M | BUY | 13.94% | 3.66M | May 11 - May 12 | View |
| Mar 30, 2023 | Robert Hopfner | DIRECTOR | 344.59K | $4.54 | $1.56M | BUY | 12.01% | 3.21M | Mar 29 | View |
| Mar 29, 2023 | Robert Hopfner | DIRECTOR | 207.84K | $4.05 | $841.06K | BUY | 7.81% | 2.87M | Mar 27 - Mar 28 | View |
| Dec 19, 2022 | Henric Bjarke | SVP, COO | 21.50K | $1.39 | $29.88K | BUY | 25.61% | 105.44K | Dec 15 | View |
| Apr 21, 2022 | Longitude Capital Partners III LLCLongitude Venture Partners III LPJuliet Bakker TammenomsPATRICK ENRIGHT | 10% OWNER | 1.35M | $3.69 | $5.00M | BUY | 48.06% | 4.17M | Apr 19 | View |
| Apr 20, 2022 | Pivotal bioVenture Partners Fund I LPPivotal bioVenture Partners Fund I GP LPPivotal bioVenture Partners Fund I UGP Ltd | DIRECTOR | 1.07M | $3.69 | $3.95M | BUY | 67.25% | 2.66M | Apr 19 | View |
| Apr 20, 2022 | Henric Bjarke | SVP, COO | 27.10K | $3.69 | $100.00K | BUY | 50.63% | 80.63K | Apr 19 | View |
| Apr 20, 2022 | Axel Bolte | CHIEF EXECUTIVE OFFICER | 67.75K | $3.69 | $250.00K | BUY | 35.50% | 258.57K | Apr 19 | View |
| Apr 20, 2022 | Robert Hopfner | DIRECTOR | 1.07M | $3.69 | $3.95M | BUY | 67.25% | 2.66M | Apr 19 | View |
| Apr 20, 2022 | Sanjay Subramanian | SVP, CFO | 27.10K | $3.69 | $100.00K | BUY | ∞ | 27.10K | Apr 19 | View |
| Jun 25, 2021 | Axel Bolte | CHIEF EXECUTIVE OFFICER | 0.00 | $0.49 | $65.45K | SELL-OPTIONS | 0.00% | 190.82K | Jun 24 | View |
| Feb 01, 2021 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | 10% OWNER | -375.00K | $21.00 | -$7.88M | SELL | -14.59% | 2.19M | Jan 28 | View |
| Jul 29, 2020 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | — | 2.57M | $16.00 | $6.00M | DERIVATIVE CONVERSION | ∞ | 2.57M | Jul 28 | View |
| Jul 29, 2020 | Sanofi | — | 520.13K | $16.00 | $1.30M | DERIVATIVE CONVERSION | ∞ | 520.13K | Jul 28 | View |
| Jul 28, 2020 | Rock Springs Capital Management LPRock Springs Capital Master Fund LPRock Springs Capital LLC | 10% OWNER | 1.07M | $16.00 | $9.60M | BUY | ∞ | 1.07M | Jul 28 | View |
| Jul 28, 2020 | RA CAPITAL MANAGEMENT LPPeter KolchinskyRajeev Shah | — | 2.00M | $16.00 | $9.60M | DERIVATIVE CONVERSION | ∞ | 2.00M | Jul 28 | View |
| Jul 28, 2020 | Peter Sonsini | — | 2.44M | $16.00 | $4.00M | DERIVATIVE CONVERSION | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | SCOTT SANDELL | 10% OWNER | 2.44M | $16.00 | $4.00M | BUY | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | JOSHUA MAKOWER | 10% OWNER | 2.44M | $16.00 | $4.00M | BUY | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | Mohamad Makhzoumi | — | 2.44M | $16.00 | $4.00M | DERIVATIVE CONVERSION | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | Anthony Florence Jr | — | 2.44M | $16.00 | $4.00M | DERIVATIVE CONVERSION | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | FOREST BASKETT | — | 2.44M | $16.00 | $4.00M | DERIVATIVE CONVERSION | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | New Enterprise Associates LPNEA Partners LPNEA GP LLC | — | 2.44M | $16.00 | $4.00M | DERIVATIVE CONVERSION | ∞ | 2.44M | Jul 28 | View |
| Jul 28, 2020 | Longitude Capital Partners III LLCLongitude Venture Partners III LPJuliet Bakker TammenomsPATRICK ENRIGHT | — | 2.82M | $16.00 | $10.00M | DERIVATIVE CONVERSION | ∞ | 2.82M | Jul 28 | View |
| Jul 28, 2020 | Pivotal bioVenture Partners Fund I LPPivotal bioVenture Partners Fund I GP LPPivotal bioVenture Partners Fund I UGP Ltd | 10% OWNER | 1.59M | $16.00 | $3.00M | BUY | ∞ | 1.59M | Jul 28 | View |
| Jul 28, 2020 | Robert Hopfner | — | 1.59M | $16.00 | $3.00M | DERIVATIVE CONVERSION | ∞ | 1.59M | Jul 28 | View |
| Jul 28, 2020 | Sofinnova Venture Partners X LPSofinnova Management X LLCJAMES HEALYMaha KatabiMICHAEL POWELL | — | 2.03M | $16.00 | $7.00M | DERIVATIVE CONVERSION | ∞ | 2.03M | Jul 28 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
